Form 4 for THC TENET HEALTHCARE CORP
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0000950170-24-026610 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-05 | 2024-03-01 | THC | Arnst Thomas W | EVP, GC, Chief Admin. Off | S - Sale+OE | $94.84 | -17.0K | 8,148 | -68% | -$1.61M |
| D | 2024-03-05 | 2024-03-01 | THC | Arnst Thomas W | EVP, GC, Chief Admin. Off | M - OptEx | — | +5,597 | 27.4K | +26% | — |
| D | 2024-03-05 | 2024-03-01 | THC | Arnst Thomas W | EVP, GC, Chief Admin. Off | F - Tax | $94.29 | -2,203 | 25.1K | -8% | -$207.7K |
| D | 2024-03-05 | 2024-03-01 | THC | Arnst Thomas W | EVP, GC, Chief Admin. Off | M - OptEx | $0.00 | +5,597 | 11.2K | +100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | S | D | 3,976 | $94.03 | 21,172 | D | — | — | (F5) The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $93.395 to $94.39. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-03-01 | M | A | 5,597 | — | 27,351 | D | — | — | (F2) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Common | Common Stock | 2024-03-01 | F | D | 2,203 | $94.29 | 25,148 | D | — | — | (F3) Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. (F4) Represents the closing price of the common stock of the Issuer on March 1, 2024. |
| 4 | Common | Common Stock | 2024-03-01 | S | D | 9,925 | $94.96 | 11,247 | D | — | — | (F6) The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $94.395 to $95.37. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2024-03-01 | S | D | 3,099 | $95.48 | 8,148 | D | — | — | (F7) The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $95.40 to $95.62. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 6 | Derivative | 2023 March Restricted Stock Units | 2024-03-01 | M | A | 5,597 | $0.00 | 11,196 | D | — · — to — | 5,597 Common Stock | (F1) The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on March 1, 2024. |